FluSure® XP/FarrowSure® Gold B and FluSure® XP/RespiSure® are combination vaccines, now available in Canada, that deliver more protection in one convenient vaccine, reducing labour costs and injections required per animal.

The two new combination vaccines both include FluSure XP – the leading swine influenza vaccine in Canada to protect herds from contemporary swine influenza virus (SIV) strains. “Protecting herds from influenza may not always be top of mind, and these new combination products make it easy and convenient to provide more complete protection with one product,“ says Walter Heuser, DVM, Swine Business Unit Director for Pfizer Animal Health.

FluSure XP/FarrowSure Gold B is registered for use in healthy breeding swine, including pregnant sows and gilts. It is the only vaccine available in Canada to aid in the prevention of respiratory disease caused by SIV subtypes H1N1 and H3N2, reproductive failure caused by porcine parvovirus (PPV), and disease caused by Erysipelothrix rhusiopathiae and six serovars of leptospira. Offspring of vaccinated females also benefit from maternal antibodies via colostum for SIV. FluSure XP/FarrowSure Gold B has demonstrated an 18-week duration of immunity against erysipelas.

FluSureXP/RespiSure is registered for use in healthy swine, three weeks of age and older, including pregnant sows and gilts. It aids in preventing respiratory disease caused by SIV subtypes H1N1 and H3N2, and Mycoplasma hyopneumoniae. FluSure XP/RespiSure has a duration of immunity of at least 10 weeks, based on significantly reduced lung lesions, against SIV H3N2.

FluSure XP/FarrowSure Gold B and FluSure XP/RespiSure are available exclusively through veterinarians. Consult your herd veterinarian as to how these products may fit your herd vaccination protocol.